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Primary ciliary dyskinesia (PCD) is a genetically heterogeneous dis-
order characterized by chronic infections of the upper and lower
airways, randomization of left/right body asymmetry, and reduced
fertility. The phenotype results from dysfunction of motile cilia of
the respiratory epithelium, at the embryonic node and of sperm
flagella. Ultrastructural defects often involve outer dynein arms
(ODAs), that are composed of several light (LCs), intermediate,
and heavy (HCs) dynein chains. We recently showed that recessive
mutations of DNAH5, the human ortholog of the biflagellate Chlamy-
domonas ODA -HC, cause PCD. In Chlamydomonas, motor protein
activity of the -ODA-HC is regulated by binding of the axonemal
LC1. We report the identification of the human (DNAL1) and murine
(Dnal1) orthologs of the Chlamydomonas LC1-gene. Northern blot
and in situ hybridization analyses revealed specific expression in
testis, embryonic node, respiratory epithelium, and ependyma, re-
sembling the DNAH5 expression pattern. In silico protein analysis
showed complete conservation of the LC1/-HC binding motif in
DNAL1. Protein interaction studies demonstrated binding of DNAL1
and DNAH5. Based on these findings, we considered DNAL1 a candi-
date for PCD and sequenced all exons of DNAL1 in 86 patients.
Mutational analysis was negative, excluding a major role of DNAL1
in the pathogenesis of PCD.
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Congenital dysfunction of motile cilia and flagella in primary
ciliary dyskinesia (PCD, MIM 242,650) (1) causes a complex
phenotype (2). The epithelia of the upper and lower respiratory
tract are densely covered with motile cilia, which constantly
move inhaled particles, cell debris, and microbes toward the
throat. Lack of mucociliary clearance due to immotile or dysmot-
ile cilia in patients with PCD leads to recurrent respiratory in-
fections that often cause permanent lung damage such as
bronchiectasis. Dysfunction of nodal cilia during early em-
bryogenesis causes randomization of left/right body asymmetry
(3), which explains that half of the affected individuals with PCD
exhibit situs inversus. The association of PCD and situs inversus
is also referred to as Kartagener’s syndrome (KS, MIM 244,400).
Male patients with PCD often report reduced fertility, which is
due to dysmotile sperm tails. Recently we identified a novel
(Received in original form October 28, 2004 and in final form March 15, 2005)
This work was supported by grants to H.O. from the German Research Foundation
DFG Om 6/2 and the SFB 592 and by the Zentrum Klinische Forschung, Freiburg.
Correspondence and requests for reprints should be addressed to Heymut Omran,
M.D., Department of Pediatrics and Adolescent Medicine, Mathildenstrasse 1,
79106 Freiburg, Germany. E-mail: omran@kikli.ukl.uni-freiburg.de
Am J Respir Cell Mol Biol Vol 33. pp 41–47, 2005
Originally Published in Press as DOI: 10.1165/rcmb.2004-0335OC on April 21, 2005
Internet address: www.atsjournals.org
biological mechanism leading to hydrocephalus formation, a rare
associated disease manifestation of PCD. Motile cilia of ependy-
mal cells that line the inner ventricles and the aqueduct of Sylvius
generate an “ependymal flow” of the cerebrospinal fluid (4).
Disruption of ependymal flow in Mdnah5 mutant mice results
in obligatory triventricular hydrocephalus due to aqueduct clo-
sure. In patients with PCD the risk for aqueduct stenosis and
consecutive triventricular hydrocephalus is significantly increased.
Electron microscopy of respiratory cilia from patients with
PCD often reveals characteristic ultrastructural defects (5), with
partial or total absence of dynein arms as the most frequent
abnormality (6). Outer (ODAs) and inner (IDAs) dynein arms
contain the molecular motors that generate the force to move
cilia by ATP-dependent reactions. ODAs are large multiprotein
complexes that consist of heavy (HCs, 400–500 kD), intermediate
(ICs, 55–110 kD), and light (LCs, 8–45 kD) dynein chains (7).
The biflagellate green alga Chlamydomonas reinhardtii has
been widely used as a model organism to study assembly and
function of the flagellar axoneme. Here, a number of mutants
with ODA and IDA defects have been reported (8). For example,
mutations of the genes encoding the ODA components IC1 and
-HC resulted in slow-swimming algae with ODA defects (9).
Using candidate approaches and positional cloning strategies,
subsequently recessive mutations in the orthologous human
ODA genes DNAI1 and DNAH5 have been identified in patients
with PCD (10, 11). Recently, we have shown that DNAH5 and
DNAH9 mislocalization is present in respiratory epithelial cells
in patients with DNAH5 and DNAI1 mutations (12). Mutations
in DNAH11 encoding a dynein HC, have been described in a
patient with PCD and normal axonemal structure (13). Ciliogen-
esis and maintenance of cilia and flagella represents a complex
mechanism that requires many individual components to be cor-
rectly assembled onto the axonemes. This is proposed to be
accomplished by a cilia/flagellar-specific transport machinery.
However, because generation of ciliary substructures (e.g.,
ODAs) is currently only at the beginning of being elucidated,
characterization and mutational analysis of candidate genes has
been employed to identify novel PCD genes over the past years.
These studies have greatly enhanced our understanding of the
pathogenic mechanisms involved in the genetically heterogenous
disease PCD. Because defects of ODAs are among the most
common ultrastructural abnormalities observed in PCD, we be-
gan to identify and characterize human genes encoding ODA
components. Based on orthology to Chlamydomonas we recently
identified the human LC-gene TCTEX (14).
Here, we report the identification and characterization of the
human (DNAL1) and murine (Dnal1) ortholog of the Chlamy-
domonas ODA-LC gene LC1. DNAL1 and DnaI1 span 49 kb
and 25 kb, respectively, and comprise eight coding exons. The
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DNAL1 transcript harbors a 573-bp ORF and encodes a 190–
amino acid (aa) protein. We show that DNAL1/Dnal1 is specifi-
cally expressed only in tissues carrying motile cilia or flagella.
We show by computational three-dimensional protein structure
comparison that the -HC binding motif of LC1 has been com-
pletely preserved in DNAL1, and demonstrate interaction with
DNAH5 by co-immunoprecipitation. Although DNAL1 repre-
sents a promising candidate gene for PCD, we did not find
mutations in this gene in affected individuals of 86 families with
PCD originating from Europe and the United States.
MATERIALS AND METHODS
Identification of the Human DNAL1 Gene and its Mouse
Ortholog Dnal1
We identified the human ortholog of the Chlamydomonas LC1-gene
by an in silico cloning strategy. The human EST database was screened
with the Chlamydomonas LC1 protein sequence (AAD41040) using
the BLAST program at NCBI (http://www.ncbi.nlm.nih.gov/BLAST/).
We obtained a clone (AA975229), which shared high homologies with
the Chlamydomonas LC1 gene and contained the human DNAL1 cod-
ing region except exon 1. The putative exon 1 and 5UTR were identified
by genomic BLAST and TWOBLAST analyses using a 14q24.3 DNAL1
genomic contig derived from two PAC clones (AC005225 and AC006146)
and the Chlamydomonas LC1 cDNA sequence (AF112476). The putative
intron-exon structure of DNAL1 was derived from genomic and cDNA
sequence alignments. The preliminary exon 1 and 5UTR of DNAL1 were
confirmed by 5-RACE using a human testis cDNA library (Marathon-
Ready cDNA; BD Biosciences Clontech, Heidelberg, Germany).
Nested amplification (Marathon cDNA Amplification Kit; Clontech)
was performed following the manufacturer’s instructions with the reverse
primers GSP_h 5-TCT CGC AAT TAG CAA GCA TGG AAG G-3
and nGSP_h 5-CAT CTT CTC TAT AGG GGG AAT CTG G-3. A
250-bp amplification product was isolated and sequenced, and the full-
length cDNA sequence was transmitted to GenBank under the Acces-
sion number AF542071. Using a similar strategy including a mouse cDNA
clone (BG916281) and a BAC clone (AC125071) from mouse chromosome
12, we also identified the murine ortholog Dnal1. The 5-end of the murine
cDNA was amplified by 5RACE using a mouse kidney cDNA library
(Clontech) and the primers GSP_m 5-TCC TCA AGT TTT TTA
GGC CAT TCA GGT TGG-3 and nGSP_m 5-ACA GAG AAA
GCT TCT CGC AGT TAC C-3.
Nothern Blot
A human multiple tissue Northern blot (Clontech) was hybridized over
night at 60 C in Church buffer (500 mM phosphate buffer pH 7.2, 7%
SDS [wt/vol], 1 mM EDTA supplemented with 100 g/ml Salmon sperm
DNA) using an 800-bp NotI-EcoRI fragment derived from the human
cDNA clone AA975229 as a probe. The DNAL1-specific probe was
radiolabeled with -32P-dCTP using a Megaprime DNA labeling kit
(Amersham, Freiburg, Germany). The filter was washed twice for
5 min at room temperature with 2 SSC/0.1%SDS and twice for 10–
15 min at 55 C with 0.2 SSC/0.1%SDS. The membrane was exposed
to an X-ray film (X-OMAT AR; Kodak, Stuttgart, Germany) in the
presence of an intensifying screen (Cronex; DuPont, Bad Homburg,
Germany) at 70 C. Equal loading of RNA was confirmed by the
manufacturer of the premade blot (Clontech).
In Situ Hybridization Analysis of Dnal1
A 1.39-kb digoxigenin-labeld antisense riboprobe derived from the
murine EST clone BG916281 was used for whole mount (embryonic
mice postcoital day 7.5) and section (adult mice) in situ hybridization
as described previously (15, 16). Color reactions were extended up to
4 d to visualize the weak expression at the node. Specimens were
transferred into 80% glycerol and photographed using a Leica DC200
digital camera on a Leica M420 photomicroscope (Leica, Solms, Ger-
many) or under Nomarski optics using a Fujix digital camera HC300Z
on a Zeiss Axioplan (Zeiss, Jena, Germany).
In Silico Protein Analysis
The program ClustalW at European Bioinformatics Institute was used
for alignments of the human DNAL1, mouse Dnal1, Chlamydomonas
LC1, and sequences of putative orthologous proteins from other species.
Based on the published three-dimensional structure of Chlamydomonas
LC1 (17), the structure of DNAL1 was calculated with use of the DALI
server (www.ebi.ac.uk/dali/) and the protein data bank (www.rcsb.org/
pdb/). Figures were prepared with the MOLMOL program (18).
Protein Interaction Studies
HEK293T cells were transiently transfected by calciumphosphate co-
precipitation with pEGFPc2 (Clontech) as control and a pEGFPc2-
DNAL1 construct containing the human full-length DNAL1 cDNA
fused in-frame to the C-terminal end of EGFP. Cells were harvested
24 h after transfection and cell lysates were prepared by NP40 lysis.
Similar expression levels were confirmed by Western blot. To obtain
sufficient amounts of dynein HC proteins, high-salt axonemal extracts
were prepared from a pig trachea as previously described (19, 20). Cell
lysates and protein extracts were mixed together and incubated overnight
with gentle agitation at 4C. Immunoprecipitation was performed using
a Protein G Immunoprecipitation Kit (Sigma, Taufkirchen, Germany)
following the manufacturer’s instructions and rabbit anti-GFP antibodies
(Clontech). Precipitation products were separated on NuPAGE 4–12%
Bis-Tris gels (Invitrogen, Karlsruhe, Germany) and blotted onto PVDF
membranes (Amersham). Blots were processed according to standard
methods using a 1:1,000 dilution of rabbit anti-DNAH5 antibodies (12)
and a 1:2,500 dilution of horseradish peroxidase–conjugated anti-rabbit
secondary antibodies (Santa Cruz, Heidelberg, Germany). Bands were
visualized with ECL plus (Amersham).
Mutational Analysis
We analyzed affected PCD individuals from 86 families for DNAL1
mutations. We included 110 PCD families originating from different
families obtained through international collaborations (Germany,
Switzerland, the United States, and Hungary) in the study. Twenty-four
PCD families were excluded, because DNAH5 or DNAI1 mutations, or
linkage to the DNAH5 locus, was identified. The remaining 86 PCD
families were included in the DNAL1 mutational analysis. We analyzed
from each family one affected individual. All affected individuals were
white. Forty-eight patients (56%) had associated situs inversus. Diagno-
sis was based on established criteria (6). Samples from five healthy
donors were included as controls. Signed and informed consent was
obtained from patients and family members using protocols approved
by the Institutional Ethics Review Board at the University of Freiburg
and collaborating institutions. Genomic DNA was isolated by standard
methods directly from blood samples or after EBV transformation of
peripheral blood lymphocytes. The eight coding exons including the
corresponding intron-exon boundaries of DNAL1 were amplified and
sequenced using following primers: Exon1F 5-TAC TCC TGT GCG
GGG TTA AG-3, Exon1R 5-ACC CTT TTC CAC TCC CAA TC-3,
Exon2F 5-CCA AGG CTA ATA GTT ATT GCT TG-3 Exon2R
5-TCA TGC ATC CAC CAC CAT AG-3, Exon3F 5-CTG GCC
TCT TTT GTT TCC AC-3, Exon3R 5-TGT TTG ACC TTG CCA
AAG AG-3, Exon4F 5-ACC ATA TTG CCC TCA AGA AG-3,
Exon4R 5-CAA CAA GTA TGG CTA AAA CAG GTG-3, Exon5F
5-CCA GCA ATT TAA GAC CAT GTG-3, Exon5R 5‘-GTG GGA
GTA CAG GTT GTT GC-3, Exon6F 5-GAC AGG CAG GGT CTA
AGT TCA C-3, Exon6R 5-TTT GCA TCT TTT CCC TCT CG-3,
Exon7F 5-CAC CCG GCC AAA ACT TAG TG-3, Exon7R 5-CTC
CTC TTC ATG ATT CCA TGC-3, Exon8F 5-ATA GTA TCT CAG
AGC TTC TCA GG-3, Exon8R 5-AGG TTG GCA TTA CCA GTT
TTG-3. PCR was performed in a volume of 50 l containing 50 pmol
primers, 2 mM dNTPs, and 1.5 U of Taq DNA polymerase (Invitrogen).
Q-Solution (Qiagen, Hilden, Germany) was added to amplify exon 1.
Amplification was performed with denaturation at 94 C for 4 min and
32 cycles of denaturation for 30 s at 94 C, annealing for 30 s at 58 C
for exon 1 and exon 3, 61C for exon 2, 4, 5, 6, 7, and 8, respectively, and
extension for 60 s at 72C. Final extension was performed at 72 C for
10 min. PCR products (exon 1, 279 bp; exon 2, 614 bp; exon 3, 322 bp;
exon 4, 287 bp; exon 5, 501 bp; exon 6, 314 bp; exon7, 271 bp; and
exon 8, 624 bp) were gel-extracted or column-purified (Qiagen) and
directly sequenced. All exons were sequenced bidirectionally. Sequence
data were compared with the corresponding genomic sequences using
TWOBLAST. The quality of the sequence data was judged using Chro-
mas (www.technelysium.com).
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RESULTS
Identification of the Human and Murine Axonemal Dynein
LC1 Genes DNAL1 and Dnal1
Applying an in silico cloning strategy (see Materials and Meth-
ods for details), we identified the genetic structure of the human
and mouse axonemal dynein LC1, DNAL1 and Dnal1. The cor-
responding cDNAs were confirmed by sequencing of EST clones,
5RACE, and PCR amplification from cDNA libraries. DNAL1
spans 49 kb, comprises eight exons, and maps to chromosome
14q24.3. All intron-exon boundaries conform to the consensus
sequences of the 5 and 3 splice sites. The putative translation
start sequence matches the Kozak consensus sequence. The mRNA
harbors an 573-bp open reading frame that encodes the 190-aa
DNAL1 protein. The predicted amino acid sequence is 54%
identical and 69% homologous to the LC1 of Chlamydomonas
rheinhardtii (Figure 1). The murine ortholog Dnal1 localizes to
chromosome 12, spans 25 kb, and contains eight coding exons.
Due to the longer 3UTR, the transcript is 1.6 kb in length. The
570-bp ORF encodes a 190-aa protein. The predicted murine
protein Dnal1 is 93% identical and 97% homologous to the
human DNAL1 (Figure 1). The strong homology of the human,
murine, and Chlamydomonas proteins, as well as the putative
orthologous proteins from other species, indicates that the func-
tion of this protein has been conserved in motile cilia and flagella
from higher organisms.
Figure 1. Sequence alignment
of human DNAL1 and its murine
Dnal1 and Chlamydomonas LC1
orthologs, respectively. The pu-
tative orthologs from other spe-
cies were obtained by BLAST
search and are also idicated.
Highlighted letters and letters on
a gray background represent
identical and conserved amino
acid residues, respectively. The
LRR consensus sequence (see
DISCUSSION for details) is shown
below each panel. Most parts
of the orthologous proteins are
highly conserved between
species. The Chlamydomonas
residues predicted to bind the
-heavy chain (the ortholog of
DNAH5) are marked with
arrows, and the residues pre-
dicted to bind p45 are indicated
with asterisks. The correspond-
ing accession numbers are:
Homo sapiens AF542071, Mus
musculus BAB24259, Chlamydo-
monas reinhardtii AAD41040,
Xenopus laevis AAH82218, Danio
rerio NP_001003442, Drosophila
melanogaster NP_610483.
High Evolutionary Conservation of the Three-Dimensional
Axonemal Dynein LC1 Protein Structure
As shown in Figure 1, the LC1 and DNAL1 amino acid sequences
deviate considerably within their N-terminal parts (aa 12–33),
within the C-terminal half (aa 153–170 including a 3-aa deletion),
and at the C-terminus (a 5-aa truncation). To test whether these
sequence variations account for changes of the steric protein
properties, we performed computational protein modeling.
Based on the solution structure of the Chlamydomonas LC1,
we predicted the three-dimensional structure of DNAL1 with
an overall root-mean-square deviation (rmsd) of 0.4 Å using
the DALI protein structure analysis program (Figure 2). These
results show that the three-dimensional structures of both or-
thologous proteins have been highly conserved during evolution.
Only subtle differences are recognizable which do not affect the
overall tertiary structures. The 3-aa deletion (aa 153–155) in the
C-terminal half of DNAL1 is positioned inside the domain that
forms -helix No. 7 of Chlamydomonas LC1. Consequently, the
DNAL1 sequence is here modeled as a loop rather than an
-helix. The C-terminal -helix No. 9 of the human LC is shorter
by about one turn due to the 5-aa truncation. Importantly, the
putative functional LC1 domains mediating protein–protein in-
teractions have been conserved in the human orthologous pro-
tein. More precisely, DNAL1 also contains the hydrophobic
patch, which is predicted to mediate the protein–protein interac-
tion between LC1 and the -HC of the ODA in Chlamydomonas.
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Figure 2. Alignment of the predicted three-dimensional structures of DNAL1 and the orthologous Chlamydomonas LC1. (A ) Computational modelling
of DNAL1. (B ) Three-dimensional structure of LC1 based on cristallographic data. (C ) The overlay of DNAL1 (yellow) and LC1 (blue) elucidates
the high conservation of both proteins. Minor differences are a loop instead of -helix No. 7 and the shortened C-terminus of DNAL1. (D )
Demonstration of interaction between DNAL1 and DNAH5 by co-immunoprecipitation. Silverstaining (top) and Western blot using anti-DNAH5
antibodies (bottom) of proteins precipitated with anti-GFP antibodies from a mixtures of axonemal extracts from porcine tracheal epithelium and
HEK293T cell lysates containing either an EGFP-DNAL1 fusion protein (left) or EGFP alone (right).
In addition, both proteins contain charged/polar residues on the
opposite face, which represents a domain with dynamic behavior
and mediates the interaction with a jet uncharacterized 45-kD
protein (17). Because of the overall structural similarities of the
Chlamydomonas LC1 and the human DNAL1 (and likewise the
murine Dnal1) we conclude that the protein functions, including
the physical interactions, have been evolutionarily conserved.
Interaction of DNAL1 with DNAH5
To test whether DNAL1 interacts with DNAH5, the human or-
tholog of the Chlamydomonas -HC, we performed protein inter-
action studies in vitro. With anti–green fluorescent protein (GFP)
antibodies, porcine DNAH5 could be readily co-precipitated from
a mixture of an axonemal protein extract from tracheal epithelium
and a lysate from HEK297T cells transiently expressing a EGFP-
DNAL1 fusion protein (Figure 2D). Porcine DNAH5 was not
detectable by Western blot using an HEK293T cell lysate con-
taining the EGFP alone expressed at comparable levels. From
these results it can be concluded that DNAL1 and DNAH5
physically interact.
Axonemal Dynein LC1 Is Specifically Expressed in Tissues
Carrying Motile Cilia
To test whether the mammalian orthologs of the Chlamydomonas
LC1 are also associated with motile cilia function, we first analyzed
the tissue specific expression of DNAL1 by hybridization of a
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multiple tissue Northern blot (Figure 3A). A specific transcript
of  0.9 kb, which correlates to the predicted transcript length,
was only identified in testis. In tissues which are supposed not
to carry motile cilia (spleen, thymus, colon, small intestine, pe-
ripheral blood leukocytes, prostate, and uterus) we did not ob-
serve DNAL1 expression. This result is consistent with a
predicted specific role of the axonemal dynein LC1 in sperm
flagella and perhaps in other motile cilia types. To confirm this
hypothesis, we characterized the expression of Dnal1 on the
cellular level by whole mount and section in situ hybridization
analyses of mouse embryos and adult animals, respectively (Fig-
ures 3B–3E). In gastrulation stage embryos (7.5 d post coitum),
expression was confined to the node (Figure 3B). At this develop-
mental stage, breakage of left/right body symmetry is initiated
by the activity of both motile and sensory nodal monocilia (21).
Therefore the specific expression within the node during this
period indicates that Dnal1 contributes to the function most
likely of the motile 90 cilia at the embryonic node. In sections
from adult mice we found specific Dnal1 expression in the respi-
ratory epithelium of the upper airways (Figure 3C) and the
ependymal cells lining the brain ventricles and the aqueduct
of Sylvius (Figures 3D–3E). Because both epithelial tissues are
densely covered with motile 92 cilia (respiratory and ependymal
cilia, respectively), these results further support a putative role of
the axonemal dynein LC1 in motile cilia of higher organisms.
Figure 3. Expression analyses of human DNAL1 and murine Dnal1. (A ) Northern blot analysis of the human DNAL1 gene shows a specific signal
of the predicted size only in testis, which is compatible with expression in sperm cells. DNAL1 mRNA expression is undetectable in tissues that do
not carry motile cilia. (B ) Whole-mount in situ hybridization analysis of Dnal1 in early gastrulation-stage mouse embryo (7.5 d.p.c.) shows specific
expression in the node (arrow). (C–E) Section in situ hybridization analysis demonstrates specific expression in ciliated respiratory epithelial cells
(C and D ) and ependymal cells of the aqueduct of Sylvius (E ).
Mutational Analysis
Although PCD represents a genetically heterogenous disease,
only three PCD genes have been identified so far. These include
DNAH5 and DNAI1, encoding heavy and intermediate chains of
the axonemal ODAs. Because of the high degree of evolutionary
conservation and the putative role specifically in motile cilia, we
considered the ODA LC gene DNAL1 a strong candidate gene
for PCD. Therefore, we amplified and sequenced all eight coding
exons of DNAL1 from a large cohort of patients with PCD
comprising 86 affected individuals. Five healthy individuals were
included as control subjects. However, among the patients with
PCD analyzed in this study, we did not detect any sequence
variants including single nucleotide polymorphisms.
DISCUSSION
Recent linkage analyses have shown that PCD represents a ge-
netically heterogenous hereditary disease. Nevertheless, only
three PCD genes have been identified to date. Whereas DNAH5
and DNAI1 encode heavy and intermediate chains of the ODAs,
the role of DNAH11 mutations is less well understood. Because
ultrastructural defects observed in PCD frequently affect the
ODAs and/or IDAs, the genes encoding their components have
often been proposed as candidate genes. In addition, mutations
causing dysfunction of dynein arms without recognizable changes
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of the axonemal ultrastructures might also contribute to the ge-
netic heterogeneity of PCD. Therefore, attempts to identify novel
PCD genes have almost exclusively been based on the analysis
of candidate genes. Here we describe the identification of the
novel human gene DNAL1 and its murine ortholog Dnal1, encod-
ing the axonemal dynein LC1. We applied an in silico cloning
strategy, which was enabled by the evolutionary conservation of
ODA proteins between the green alga Chlamydomonas and verte-
brates. The high degree of amino acid sequence conservation of
DNAL1, Dnal1, and the Chlamydomonas LC1 ortholog suggests
that the functional role has also been evolutionarily preserved
(Figure 1). This is further supported by the three-dimensional
protein structures, which show only marginal differences
(Figure 2).
In Chlamydomonas flagella, LC1 participates in the large
multimeric ODA complex, and physically interacts with the axo-
nemal -HC (22). LC1 is a member of the SDS22 subclass of
the leucin-rich repeat (LRR) family. Refined solution structure
showed that the LRR region folds as a right-handed spiral with
six 	-	--motifs that form two parallel 	sheets and an -helical
face (17, 23, 24). The first 	-sheet exhibits a single hydrophobic
patch that is predicted to bind the -HC in close vicinity of
the ATP hydrolytic site of the motor domain. Stoichiometry
measurements indicated that two LC1 molecules bind to each
-HC. Furthermore, crosslinking experiments suggested that
LC1 forms a ternary complex and also interacts with a yet uniden-
tified 45-kD protein (22). Therefore, it has been predicted that
the motor protein activity of the -HC is regulated through
interaction with LC1, which mediates the signals originating from
environmental stimuli. Because of the high sequence and struc-
tural similarities, we assumed that DNAL1 might interact with
DNAH5, the human ortholog of the Chlamydomonas -HC,
which we previously showed to be involved in the pathogenesis
of PCD (11). Using immunoprecipitation studies we demonstrated
that GFP-tagged DNAL1 binds to native DNAH5 present in
axonemal extracts of pig respiratory epithelial cells (Figure 2D).
We demonstrated specific co-expression of DNAL1 (Dnal1)
and DNAH5 (Mdnah5) in tissues known to carry motile cilia
(respiratory epithelia and ependyma) or flagella (sperm cells)
and absence of expression in non-ciliated tissues or tissues con-
taining sensory cilia (Figure 2) like retina and kidney (4, 11,
25). This suggests a regulatory function of DNAL1/Dnal1 for
DNAH5/Mdnah5 activity in outer dynein arms of sperm flagella,
respiratory cilia, and ependymal cilia.
Based on the predicted functions of DNAL1, we considered
DNAL1 an excellent candidate gene for PCD. Because muta-
tions in the Chlamydomonas -HC gene and human ortholog
DNAH5 cause slow-swimming algae or PCD with ODA defects,
respectively, we hypothesized that nonfunctional DNAL1 might
also cause dysmotility of cilia and flagella due to impaired regula-
tory functions. However, in a large cohort of patients with PCD,
we did not detect sequence variations within the coding exons
of DNAL1, which excludes a major role in the etiology of PCD.
One possible reason for the absence of DNAL1 mutations
in patients with PCD might be an essential requirement for
correct function of DNAL1 in motile cilia during development.
Another possibility is that DNAL1 exhibits additional functions
outside the ciliary compartment. Because cilia share a number
of proteins with the cytoplasm (e.g., the retrograde intraflagellar
transport process is dependent on cytoplasmic dynein motors
[26]) nonfunctional components might lead to cell death rather
than dysmotile cilia.
In summary, we identified the human DNAL1 and murine
Dnal1 gene, respectively, elucidated the intron-exon structures
and cDNA sequences, and demonstrated interaction of DNAL1
and DNAH5. The strong mRNA expression in testis suggests
that DNAL1 might play a particular role in sperm flagella, and
raises the possibility that DNAL1 mutations are involved in male
sterility.
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